Form 8-K - Current report:
SEC Accession No. 0001445305-13-000444
Filing Date
2013-03-04
Accepted
2013-03-01 17:53:29
Documents
2
Period of Report
2013-03-01
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K cpix20121231-earningsrelea.htm 8-K 313677
2 cumberlandpharmaceuti_image1.jpg GRAPHIC 37721
  Complete submission text file 0001445305-13-000444.txt   366843
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13659327
SIC: 2834 Pharmaceutical Preparations